A 
3.15
+12.90%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$84.3m
FY2018FY2025
Net income
−$171.3m
FY2018FY2025
Free cash flow
−$171.2m
FY2018FY2025
Shareholders' equity
$114.3m
FY2018FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $84.3m | $89.1m | $30,000 | $1.3m | $5.5m | $17.8m | — | — |
| Research and development | $13.2m | $19.6m | $20.3m | $18.4m | $20.3m | $14.1m | $21.5m | $14.8m |
| Operating income | −$179.4m | −$3.1m | −$67.5m | −$35.5m | −$19.5m | −$469,000 | −$24.1m | −$18.3m |
| Net income | −$171.3m | $8.0m | −$54.4m | −$34.7m | −$20.2m | −$1.1m | −$24.0m | −$17.6m |
| Diluted earnings per share | -1.74 | 0.08 | -0.57 | -0.37 | -0.58 | -0.03 | -0.72 | -0.53 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | $327.7m | $351.2m | $233.2m | $281.4m | $61.4m | $26.4m | $15.6m | $27.5m |
| Cash and short-term investments | $245.0m | $314.0m | $228.4m | $274.4m | $60.1m | $24.5m | $10.0m | $20.2m |
| Total liabilities | $213.4m | $94.4m | $2.4m | $8.5m | $92.7m | $40.5m | $21.3m | $9.3m |
| Debt | $97.0m | — | — | — | — | $800,000 | $11.5m | $2.8m |
| Shareholders' equity | $114.3m | $256.8m | $230.8m | $272.9m | −$31.3m | −$14.1m | −$5.6m | $18.2m |
| Shares outstanding | 99m | 98m | 96m | 94m | 35m | 35m | 33m | 33m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$170.9m | $13.5m | −$59.3m | −$40.1m | −$17.6m | $9.1m | −$18.9m | −$16.9m |
| Capital spending | −$339,000 | −$563,000 | −$175,000 | −$199,000 | −$55,000 | −$917,000 | −$96,000 | −$449,000 |
| Free cash flow | −$171.2m | $13.0m | −$59.4m | −$40.3m | −$17.6m | $8.2m | −$19.0m | −$17.3m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33.7m | $22.7m | $28.1m | $32.5m | $15.7m | $8.0m | $86.6m | $2.1m |
| Operating income | −$61.5m | −$60.1m | −$41.5m | −$53.2m | −$47.6m | −$37.2m | $47.2m | −$21.7m |
| Net income | −$62.3m | −$60.6m | −$41.3m | −$51.2m | −$44.9m | −$33.9m | $49.9m | −$19.1m |
| Diluted earnings per share | -0.63 | -0.61 | -0.42 | -0.52 | -0.46 | -0.34 | 0.51 | -0.20 |
| Cash from operations | −$60.0m | −$44.0m | −$43.0m | −$47.0m | −$39.0m | −$40.0m | $42.0m | −$14.0m |
| Total assets | $249.5m | $287.6m | $327.7m | $372.8m | $313.5m | $327.3m | $351.2m | $217.6m |
| Cash and short-term investments | $143.8m | $201.0m | $245.0m | $288.2m | $240.1m | $275.7m | $314.0m | $204.6m |
| Debt | — | $97.1m | $97.0m | $96.8m | $589,000 | $73,000 | $42,000 | $102,000 |
| Shareholders' equity | $12.5m | $61.3m | $114.3m | $147.7m | $192.3m | $229.0m | $256.8m | $201.0m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 300.1% | 36.4% | — |
| Operating income | 71.6% | 228.5% | — |
| Net income | 70.3% | 176.2% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -105.2% | -163.4% | -154.2% | — |
| Net margin | -94.2% | -144.4% | -138.1% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | -6.7 | 129.2 | -9.7 | -10.2 | -5.1 | -667.5 |
| Price to sales | 13.6 | 11.6 | — | 269.4 | 18.7 | 39.9 |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Return | -10% | 109% | 51% | 18% | -79% | 27% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 1-to-1 reverse split · 9 Nov 2022
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.